Aldeyra Therapeutics
ALDX
$3.93
Share price
-0.25%
Change (1 day)
-58.76%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) Fails to deliver data
Key failure to deliver metrics for Aldeyra Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.07 M
- Last year FTD volume: $14.63 M
Failures to deliver for Aldeyra Therapeutics (ALDX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Aldeyra Therapeutics (ALDX) - since 2014
Volume in USD (price x number of shares), data since 2014Aldeyra Therapeutics (ALDX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.07 M | -99.52% |
| 2023 | $14.7 M | 253.25% |
| 2022 | $4.16 M | -63.67% |
| 2021 | $11.46 M | 14.77% |
| 2020 | $9.98 M | 51.06% |
| 2019 | $6.61 M | -58.59% |
| 2018 | $15.96 M | 679.47% |
| 2017 | $2.04 M | 178.61% |
| 2016 | $0.73 M | -46.37% |
| 2015 | $1.37 M | -62.17% |
| 2014 | $3.62 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $59.04 M | $0.14 B | 🇺🇸 USA |